Literature DB >> 8920866

Decreased tumor surveillance in perforin-deficient mice.

M E van den Broek1, D Kägi, F Ossendorp, R Toes, S Vamvakas, W K Lutz, C J Melief, R M Zinkernagel, H Hengartner.   

Abstract

Immune surveillance against tumors usually depends on T cell recognition of tumor antigens presented by major histocompatibility complex (MHC) molecules, whereas MHC class I- tumors may be controlled by natural killer (NK) cells. Perforin-dependent cytotoxicity is a major effector function of CD8+ MHC class I-restricted T cells and of NK cells. Here, we used perforin-deficient C57BL/6 (PKO) mice to study involvement of perforin and Fas ligand in tumor surveillance in vivo. We induced tumors in PKO and normal C57BL/6 mice by (a) injection of different syngeneic tumor cell lines of different tissue origin in naive and primed mice; (b) administration of the chemical carcinogens methylcholanthrene (MCA) or 12-O-tetradecanoylphorbol-13-acetate (TPA) plus 7,12-dimethylbenzanthracene (DMBA), or (c) by injection of acutely oncogenic Moloney sarcoma virus. The first set of models analyzes the defense against a tumor load given at once, whereas the last two sets give information on immune defense against tumors at the very moment of their generation. Most of the tumor cell lines tested were eliminated 10-100-fold better by C57BL/6 mice in an unprimed situation; after priming, the differences were more pronounced. Lymphoma cells transfected with Fas were controlled 10-fold better by PKO and C57BL/6 mice when compared to untransfected control cells, indicating some role for FasL in tumor control. MCA-induced tumors arose more rapidly and with a higher incidence in PKO mice compared to C57BL/6 or CD8-deficient mice. DMBA+TPA-induced skin papillomas arose with similar high incidence and comparable kinetics in both mouse strains. C57BL/6 and PKO mice have a similar incidence of Moloney murine sarcoma and leukemia virus-induced sarcomas, but tumors are larger and regression is retarded in PKO mice. Thus, perforin-dependent cytotoxicity is not only a crucial mechanism of both cytotoxic T lymphocyte- and NK-dependent resistance to injected tumor cell lines, but also operates during viral and chemical carcinogenesis in vivo. Experiments addressing the role of Fas-dependent cytotoxicity by studying resistance to tumor cell lines that were stably transfected with Fas neither provided evidence for a major role of Fas nor excluded a minor contribution of Fas in tumor surveillance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8920866      PMCID: PMC2192859          DOI: 10.1084/jem.184.5.1781

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.

Authors:  S P Cobbold; A Jayasuriya; A Nash; T D Prospero; H Waldmann
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

2.  Selective incorporation of H-2 antigenic determinants into Friend virus particles.

Authors:  J E Bubbers; F Lilly
Journal:  Nature       Date:  1977-03-31       Impact factor: 49.962

Review 3.  The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?

Authors:  J P Levy; J C Leclerc
Journal:  Adv Cancer Res       Date:  1977       Impact factor: 6.242

4.  Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity.

Authors:  R Bernards; P I Schrier; A Houweling; J L Bos; A J van der Eb; M Zijlstra; C J Melief
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

5.  A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.

Authors:  M J Stukart; A Vos; J Boes; R W Melvold; D W Bailey; C J Melief
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

6.  Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells.

Authors:  P I Schrier; R Bernards; R T Vaessen; A Houweling; A J van der Eb
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

7.  Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease.

Authors:  M Y Braun; B Lowin; L French; H Acha-Orbea; J Tschopp
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

8.  Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype.

Authors:  P C Doherty; W E Biddison; J R Bennink; B B Knowles
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

9.  Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.

Authors:  C Uyttenhove; J Maryanski; T Boon
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

10.  Nonrandom inclusion of H-2K and H-2D antigens in Friend virus particles from mice of various strains.

Authors:  J E Bubbers; S Chen; F Lilly
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

View more
  130 in total

1.  How to induce involuntary suicide: the need for dipeptidyl peptidase I.

Authors:  E R Podack
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

2.  Evidence for a perforin-mediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection.

Authors:  Andrea Henriques-Pons; Gabriel M Oliveira; Mauricio M Paiva; Alexandre F S Correa; Marcos M Batista; Rodrigo C Bisaggio; Chau-Ching Liu; Vinicius Cotta-De-Almeida; Claudia M L M Coutinho; Pedro M Persechini; Tania C Araujo-Jorge
Journal:  Int J Exp Pathol       Date:  2002-04       Impact factor: 1.925

Review 3.  Microenvironment abnormalities and lymphomagenesis: Immunological aspects.

Authors:  Joseph G Taylor; John G Gribben
Journal:  Semin Cancer Biol       Date:  2015-07-29       Impact factor: 15.707

Review 4.  A Believer's Overview of Cancer Immunosurveillance and Immunotherapy.

Authors:  Olivera J Finn
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

Review 5.  Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.

Authors:  Fade Mahmoud; Bradley Shields; Issam Makhoul; Nathan Avaritt; Henry K Wong; Laura F Hutchins; Sara Shalin; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2017-05-17       Impact factor: 4.742

6.  Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure.

Authors:  Alexandre Harari; Felicitas Bellutti Enders; Cristina Cellerai; Pierre-Alexandre Bart; Giuseppe Pantaleo
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

Review 7.  Prospects and challenges of building a cancer vaccine targeting telomerase.

Authors:  Robert H Vonderheide
Journal:  Biochimie       Date:  2007-07-17       Impact factor: 4.079

8.  Bacteria associated with immunoregulatory cells in mice.

Authors:  Laura L Presley; Bo Wei; Jonathan Braun; James Borneman
Journal:  Appl Environ Microbiol       Date:  2009-12-11       Impact factor: 4.792

Review 9.  Immune surveillance of tumors.

Authors:  Jeremy B Swann; Mark J Smyth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 10.  Interferon-gamma and cancer immunoediting.

Authors:  Gavin P Dunn; Hiroaki Ikeda; Allen T Bruce; Catherine Koebel; Ravi Uppaluri; Jack Bui; Ruby Chan; Mark Diamond; J Michael White; Kathleen C F Sheehan; Robert D Schreiber
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.